Chitogenx Inc. (TSE:CHGX) has released an update.
ChitogenX Inc., a company specializing in regenerative medicine, has announced the departure of their CEO, Philippe Deschamps, and his resignation from the Board of Directors for personal reasons, effective immediately. Chairman Pierre Laurin will serve as the interim CEO as the company searches for a permanent replacement. The company acknowledges Deschamps’ contributions and confirms his support during the transition period.
For further insights into TSE:CHGX stock, check out TipRanks’ Stock Analysis page.
